Cargando…
AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393074/ https://www.ncbi.nlm.nih.gov/pubmed/35988157 http://dx.doi.org/10.1002/ctm2.952 |
| _version_ | 1784771190824370176 |
|---|---|
| author | Millington‐Ward, Sophia Chadderton, Naomi Finnegan, Laura K. Post, Iris J.M. Carrigan, Matthew Gardiner, Tom Peixoto, Elisa Maloney, Daniel Humphries, Marian M. Stitt, Alan Léveillard, Thierry Humphries, Pete Kenna, Paul F. Palfi, Arpad Farrar, G. Jane |
| author_facet | Millington‐Ward, Sophia Chadderton, Naomi Finnegan, Laura K. Post, Iris J.M. Carrigan, Matthew Gardiner, Tom Peixoto, Elisa Maloney, Daniel Humphries, Marian M. Stitt, Alan Léveillard, Thierry Humphries, Pete Kenna, Paul F. Palfi, Arpad Farrar, G. Jane |
| author_sort | Millington‐Ward, Sophia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9393074 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93930742022-08-24 AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models Millington‐Ward, Sophia Chadderton, Naomi Finnegan, Laura K. Post, Iris J.M. Carrigan, Matthew Gardiner, Tom Peixoto, Elisa Maloney, Daniel Humphries, Marian M. Stitt, Alan Léveillard, Thierry Humphries, Pete Kenna, Paul F. Palfi, Arpad Farrar, G. Jane Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-08-21 /pmc/articles/PMC9393074/ /pubmed/35988157 http://dx.doi.org/10.1002/ctm2.952 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Millington‐Ward, Sophia Chadderton, Naomi Finnegan, Laura K. Post, Iris J.M. Carrigan, Matthew Gardiner, Tom Peixoto, Elisa Maloney, Daniel Humphries, Marian M. Stitt, Alan Léveillard, Thierry Humphries, Pete Kenna, Paul F. Palfi, Arpad Farrar, G. Jane AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models |
| title | AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models |
| title_full | AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models |
| title_fullStr | AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models |
| title_full_unstemmed | AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models |
| title_short | AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models |
| title_sort | aav‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393074/ https://www.ncbi.nlm.nih.gov/pubmed/35988157 http://dx.doi.org/10.1002/ctm2.952 |
| work_keys_str_mv | AT millingtonwardsophia aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT chaddertonnaomi aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT finneganlaurak aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT postirisjm aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT carriganmatthew aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT gardinertom aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT peixotoelisa aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT maloneydaniel aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT humphriesmarianm aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT stittalan aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT leveillardthierry aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT humphriespete aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT kennapaulf aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT palfiarpad aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels AT farrargjane aavmediatedgenetherapyimprovingmitochondrialfunctionprovidesbenefitinagerelatedmaculardegenerationmodels |